AAPG
Price
$24.30
Change
+$0.97 (+4.16%)
Updated
Feb 4, 12:24 PM (EDT)
Capitalization
2.2B
56 days until earnings call
Intraday BUY SELL Signals
ALZN
Price
$2.08
Change
-$0.01 (-0.48%)
Updated
Feb 4, 02:15 PM (EDT)
Capitalization
7.95M
Intraday BUY SELL Signals
Interact to see
Advertisement

AAPG vs ALZN

Header iconAAPG vs ALZN Comparison
Open Charts AAPG vs ALZNBanner chart's image
Ascentage Pharma Group
Price$24.30
Change+$0.97 (+4.16%)
Volume$100
Capitalization2.2B
Alzamend Neuro
Price$2.08
Change-$0.01 (-0.48%)
Volume$100
Capitalization7.95M
AAPG vs ALZN Comparison Chart in %
AAPG
Daily Signal:
Gain/Loss:
ALZN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AAPG vs. ALZN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAPG is a Hold and ALZN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (AAPG: $23.33 vs. ALZN: $2.09)
Brand notoriety: AAPG and ALZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAPG: 70% vs. ALZN: 56%
Market capitalization -- AAPG: $2.2B vs. ALZN: $7.95M
AAPG [@Biotechnology] is valued at $2.2B. ALZN’s [@Biotechnology] market capitalization is $7.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAPG’s FA Score shows that 0 FA rating(s) are green whileALZN’s FA Score has 1 green FA rating(s).

  • AAPG’s FA Score: 0 green, 5 red.
  • ALZN’s FA Score: 1 green, 4 red.
According to our system of comparison, ALZN is a better buy in the long-term than AAPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAPG’s TA Score shows that 2 TA indicator(s) are bullish while ALZN’s TA Score has 5 bullish TA indicator(s).

  • AAPG’s TA Score: 2 bullish, 4 bearish.
  • ALZN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than AAPG.

Price Growth

AAPG (@Biotechnology) experienced а -8.83% price change this week, while ALZN (@Biotechnology) price change was -4.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

AAPG is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAPG($2.2B) has a higher market cap than ALZN($7.95M). ALZN YTD gains are higher at: 14.835 vs. AAPG (-11.090). ALZN has higher annual earnings (EBITDA): -5.79M vs. AAPG (-1.09B). AAPG has more cash in the bank: 1.66B vs. ALZN (4.45M). ALZN has less debt than AAPG: ALZN (301K) vs AAPG (1.72B). AAPG has higher revenues than ALZN: AAPG (391M) vs ALZN (0).
AAPGALZNAAPG / ALZN
Capitalization2.2B7.95M27,703%
EBITDA-1.09B-5.79M18,731%
Gain YTD-11.09014.835-75%
P/E RatioN/AN/A-
Revenue391M0-
Total Cash1.66B4.45M37,334%
Total Debt1.72B301K570,100%
TECHNICAL ANALYSIS
Technical Analysis
AAPGALZN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
AAPG
Daily Signal:
Gain/Loss:
ALZN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLNIX25.180.07
+0.28%
MFS Global New Discovery I
GGOSX7.93-0.01
-0.13%
Goldman Sachs Mid Cap Growth Svc
JHTCX21.00-0.12
-0.57%
JPMorgan Hedged Equity 3 C
QKBGX22.30-0.17
-0.76%
Federated Hermes MDT Balanced R6
LGRNX31.98-0.77
-2.35%
Loomis Sayles Growth N

AAPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAPG has been loosely correlated with ZLAB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AAPG jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAPG
1D Price
Change %
AAPG100%
+0.69%
ZLAB - AAPG
45%
Loosely correlated
+0.80%
ONC - AAPG
38%
Loosely correlated
+0.40%
PRTC - AAPG
31%
Poorly correlated
+0.59%
ORIC - AAPG
27%
Poorly correlated
-1.43%
ALZN - AAPG
24%
Poorly correlated
-3.69%
More

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-3.69%
SRPT - ALZN
49%
Loosely correlated
-2.12%
VRAX - ALZN
46%
Loosely correlated
-1.84%
SNSE - ALZN
41%
Loosely correlated
-1.04%
ASBP - ALZN
38%
Loosely correlated
-4.12%
BPMUF - ALZN
36%
Loosely correlated
N/A
More